A new study reports that teleost type I interferon may do more than its well-known antiviral job. Researchers describe a noncanonical bactericidal activity in which teleost interferon appears able to kill bacteria, with the effect linked to a membrane-targeting C-terminal peptide.
Interferons are typically understood as immune cytokines that help organisms fight viral infections. In this case, the authors point to the pathogen-rich aquatic environment as a possible reason teleost fish evolved broader and more flexible immune defenses than previously appreciated.
The central finding is that the antibacterial effect is conferred by a C-terminal peptide that targets membranes. That suggests the molecule is not acting only through the classic interferon pathway of immune signaling, but may also have a more direct role in damaging or disrupting bacterial targets.
The work adds to growing interest in how immune systems evolve in different environments. By showing that teleost type I interferon may combine antiviral signaling with direct bactericidal activity, the study highlights a more versatile picture of fish immunity and opens new questions about immune function in aquatic vertebrates.
